(HII) Huntington Ingalls - Overview
Sector: IndustrialsIndustry: Aerospace & Defense | Exchange NYSE (USA) | Currency USD | Market Cap: 15.562m | Total Return 92.8% in 12m
Stock: Naval Ships, Nuclear Ships, Ship Repair, Defense Systems, Uncrewed
Total Rating 65
Risk 84
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 36.4% |
| Relative Tail Risk | -19.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.01 |
| Alpha | 82.25 |
| Character TTM | |
|---|---|
| Beta | 0.388 |
| Beta Downside | 0.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.21% |
| CAGR/Max DD | 0.57 |
EPS (Earnings per Share)
Revenue
Description: HII Huntington Ingalls March 05, 2026
Huntington Ingalls Industries (HII) designs, builds, overhauls, and repairs military ships for the U.S. Navy and Coast Guard. The company operates in three segments: Ingalls, Newport News, and Mission Technologies. This business model relies heavily on long-term government contracts.
HII constructs both non-nuclear ships, including amphibious assault ships and surface combatants, and nuclear-powered vessels like aircraft carriers and submarines. The company also provides refueling, overhaul, and inactivation services for nuclear-powered aircraft carriers. The defense shipbuilding sector is characterized by high barriers to entry due to specialized infrastructure and expertise.
Additionally, HII offers naval nuclear support services, including design, construction, maintenance, and disposal for in-service U.S. Navy nuclear ships. Their Mission Technologies segment focuses on advanced defense solutions such as C5ISR systems, AI/machine learning for battlefield decisions, cybersecurity, electronic warfare, and uncrewed autonomous systems. Investors interested in defense contractors might find further details on ValueRay helpful.
Headlines to watch out for
- US Navy shipbuilding budget directly impacts new contract awards
- Government defense spending fluctuations influence order backlogs
- Supply chain disruptions increase material and labor costs
- Regulatory changes in defense procurement affect profitability
- Geopolitical tensions drive demand for naval vessels
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 605.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 6.03 > 1.0 |
| NWC/Revenue: 3.25% < 20% (prev 2.05%; Δ 1.20% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.20b > Net Income 605.0m |
| Net Debt (2.37b) to EBITDA (1.21b): 1.96 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.4m) vs 12m ago 0.77% < -2% |
| Gross Margin: 12.70% > 18% (prev 0.13%; Δ 1.26k% > 0.5%) |
| Asset Turnover: 100.3% > 50% (prev 95.01%; Δ 5.30% > 0%) |
| Interest Coverage Ratio: 8.40 > 6 (EBITDA TTM 1.21b / Interest Expense TTM 105.0m) |
Altman Z'' 2.83
| A: 0.03 (Total Current Assets 3.45b - Total Current Liabilities 3.04b) / Total Assets 12.75b |
| B: 0.43 (Retained Earnings 5.49b / Total Assets 12.75b) |
| C: 0.07 (EBIT TTM 882.0m / Avg Total Assets 12.45b) |
| D: 0.71 (Book Value of Equity 5.43b / Total Liabilities 7.68b) |
| Altman-Z'' Score: 2.83 = A |
Beneish M -3.00
| DSRI: 1.05 (Receivables 2.38b/2.10b, Revenue 12.48b/11.54b) |
| GMI: 0.99 (GM 12.70% / 12.57%) |
| AQI: 0.97 (AQ_t 0.42 / AQ_t-1 0.43) |
| SGI: 1.08 (Revenue 12.48b / 11.54b) |
| TATA: -0.05 (NI 605.0m - CFO 1.20b) / TA 12.75b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = AA |
What is the price of HII shares?
As of March 27, 2026, the stock is trading at USD 384.79 with a total of 470,435 shares traded.
Over the past week, the price has changed by -8.04%, over one month by -12.87%, over three months by +9.93% and over the past year by +92.83%.
Over the past week, the price has changed by -8.04%, over one month by -12.87%, over three months by +9.93% and over the past year by +92.83%.
Is HII a buy, sell or hold?
Huntington Ingalls has received a consensus analysts rating of 3.38.
Therefor, it is recommend to hold HII.
- StrongBuy: 2
- Buy: 2
- Hold: 8
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 403 | 4.7% |
| Analysts Target Price | 403 | 4.7% |
HII Fundamental Data Overview March 25, 2026
P/E Trailing = 25.768
P/E Forward = 22.6757
P/S = 1.2466
P/B = 3.156
P/EG = 1.7418
Revenue TTM = 12.48b USD
EBIT TTM = 882.0m USD
EBITDA TTM = 1.21b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 3.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 17.93b USD (15.56b + Debt 3.15b - CCE 774.0m)
Interest Coverage Ratio = 8.40 (Ebit TTM 882.0m / Interest Expense TTM 105.0m)
EV/FCF = 16.89x (Enterprise Value 17.93b / FCF TTM 1.06b)
FCF Yield = 5.92% (FCF TTM 1.06b / Enterprise Value 17.93b)
FCF Margin = 8.51% (FCF TTM 1.06b / Revenue TTM 12.48b)
Net Margin = 4.85% (Net Income TTM 605.0m / Revenue TTM 12.48b)
Gross Margin = 12.70% ((Revenue TTM 12.48b - Cost of Revenue TTM 10.90b) / Revenue TTM)
Gross Margin QoQ = 11.57% (prev 12.34%)
Tobins Q-Ratio = 1.41 (Enterprise Value 17.93b / Total Assets 12.75b)
Interest Expense / Debt = 0.83% (Interest Expense 26.0m / Debt 3.15b)
Taxrate = 19.70% (39.0m / 198.0m)
NOPAT = 708.3m (EBIT 882.0m * (1 - 19.70%))
Current Ratio = 1.13 (Total Current Assets 3.45b / Total Current Liabilities 3.04b)
Debt / Equity = 0.62 (Debt 3.15b / totalStockholderEquity, last quarter 5.07b)
Debt / EBITDA = 1.96 (Net Debt 2.37b / EBITDA 1.21b)
Debt / FCF = 2.23 (Net Debt 2.37b / FCF TTM 1.06b)
Total Stockholder Equity = 4.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.86% (Net Income 605.0m / Total Assets 12.75b)
RoE = 12.28% (Net Income TTM 605.0m / Total Stockholder Equity 4.93b)
RoCE = 11.56% (EBIT 882.0m / Capital Employed (Equity 4.93b + L.T.Debt 2.70b))
RoIC = 9.13% (NOPAT 708.3m / Invested Capital 7.75b)
WACC = 6.23% (E(15.56b)/V(18.71b) * Re(7.35%) + D(3.15b)/V(18.71b) * Rd(0.83%) * (1-Tc(0.20)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF] Terminal Value 86.74% ; FCFF base≈748.8m ; Y1≈859.5m ; Y5≈1.20b
[DCF] Fair Price = 772.7 (EV 32.70b - Net Debt 2.37b = Equity 30.32b / Shares 39.2m; r=6.23% [WACC]; 5y FCF grow 17.29% → 3.0% )
EPS Correlation: 4.96 | EPS CAGR: 3.90% | SUE: 0.20 | # QB: 0
Revenue Correlation: 77.26 | Revenue CAGR: 8.32% | SUE: 2.18 | # QB: 3
EPS next Quarter (2026-06-30): EPS=4.26 | Chg7d=+0.000 | Chg30d=-0.128 | Revisions Net=-4 | Analysts=10
EPS current Year (2026-12-31): EPS=17.35 | Chg7d=+0.000 | Chg30d=-0.305 | Revisions Net=-4 | Growth EPS=+12.7% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=20.31 | Chg7d=+0.000 | Chg30d=-0.086 | Revisions Net=-2 | Growth EPS=+17.1% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 7.9% - Earnings Yield 3.9%)
[Growth] Growth Spread = -1.0% (Analyst 3.0% - Implied 4.0%)
P/E Forward = 22.6757
P/S = 1.2466
P/B = 3.156
P/EG = 1.7418
Revenue TTM = 12.48b USD
EBIT TTM = 882.0m USD
EBITDA TTM = 1.21b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 3.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 17.93b USD (15.56b + Debt 3.15b - CCE 774.0m)
Interest Coverage Ratio = 8.40 (Ebit TTM 882.0m / Interest Expense TTM 105.0m)
EV/FCF = 16.89x (Enterprise Value 17.93b / FCF TTM 1.06b)
FCF Yield = 5.92% (FCF TTM 1.06b / Enterprise Value 17.93b)
FCF Margin = 8.51% (FCF TTM 1.06b / Revenue TTM 12.48b)
Net Margin = 4.85% (Net Income TTM 605.0m / Revenue TTM 12.48b)
Gross Margin = 12.70% ((Revenue TTM 12.48b - Cost of Revenue TTM 10.90b) / Revenue TTM)
Gross Margin QoQ = 11.57% (prev 12.34%)
Tobins Q-Ratio = 1.41 (Enterprise Value 17.93b / Total Assets 12.75b)
Interest Expense / Debt = 0.83% (Interest Expense 26.0m / Debt 3.15b)
Taxrate = 19.70% (39.0m / 198.0m)
NOPAT = 708.3m (EBIT 882.0m * (1 - 19.70%))
Current Ratio = 1.13 (Total Current Assets 3.45b / Total Current Liabilities 3.04b)
Debt / Equity = 0.62 (Debt 3.15b / totalStockholderEquity, last quarter 5.07b)
Debt / EBITDA = 1.96 (Net Debt 2.37b / EBITDA 1.21b)
Debt / FCF = 2.23 (Net Debt 2.37b / FCF TTM 1.06b)
Total Stockholder Equity = 4.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.86% (Net Income 605.0m / Total Assets 12.75b)
RoE = 12.28% (Net Income TTM 605.0m / Total Stockholder Equity 4.93b)
RoCE = 11.56% (EBIT 882.0m / Capital Employed (Equity 4.93b + L.T.Debt 2.70b))
RoIC = 9.13% (NOPAT 708.3m / Invested Capital 7.75b)
WACC = 6.23% (E(15.56b)/V(18.71b) * Re(7.35%) + D(3.15b)/V(18.71b) * Rd(0.83%) * (1-Tc(0.20)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF] Terminal Value 86.74% ; FCFF base≈748.8m ; Y1≈859.5m ; Y5≈1.20b
[DCF] Fair Price = 772.7 (EV 32.70b - Net Debt 2.37b = Equity 30.32b / Shares 39.2m; r=6.23% [WACC]; 5y FCF grow 17.29% → 3.0% )
EPS Correlation: 4.96 | EPS CAGR: 3.90% | SUE: 0.20 | # QB: 0
Revenue Correlation: 77.26 | Revenue CAGR: 8.32% | SUE: 2.18 | # QB: 3
EPS next Quarter (2026-06-30): EPS=4.26 | Chg7d=+0.000 | Chg30d=-0.128 | Revisions Net=-4 | Analysts=10
EPS current Year (2026-12-31): EPS=17.35 | Chg7d=+0.000 | Chg30d=-0.305 | Revisions Net=-4 | Growth EPS=+12.7% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=20.31 | Chg7d=+0.000 | Chg30d=-0.086 | Revisions Net=-2 | Growth EPS=+17.1% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 7.9% - Earnings Yield 3.9%)
[Growth] Growth Spread = -1.0% (Analyst 3.0% - Implied 4.0%)